METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150218539A1
SERIAL NO

14422112

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an activator of the calcineurin subunit Aβ1 isofomi (CnAβ1) or of the C-terminal domain of the calcineurin subunit Aβ1 isofomi (Cn1) for the production of a medicament for the modulation of myocardial growth without adversely affecting contractile function.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EMBL EUROPEAN MOLECULAR BIOLOGY LABORATORY69117 HEIDELBERG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gómez, Salinero Jesús Madrid, ES 1 0
López, Olaneta Marina Madrid, ES 1 0
Lara, Pezzi Enrique Madrid, ES 1 0
Rosenthal, Nadia Heidelberg, DE 5 8
Villalba, Orero Maria Madrid, ES 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation